Concourse Financial Group Securities, Inc. Neogenomics Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 98 shares of NEO stock, worth $1,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98
Previous 98 -0.0%
Holding current value
$1,602
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
SELL
$7.86 - $12.91 $393 - $645
-50 Reduced 33.78%
98 $1,000
Q1 2022

May 09, 2022
SELL
$12.15 - $35.28 $4,143 - $12,030
-341 Reduced 69.73%
148 $2,000
Q3 2021

Nov 09, 2021
SELL
$41.66 - $52.52 $22,912 - $28,886
-550 Reduced 52.94%
489 $24,000
Q2 2021

Aug 13, 2021
SELL
$36.62 - $51.69 $1,830 - $2,584
-50 Reduced 4.59%
1,039 $46,000
Q1 2021

May 13, 2021
BUY
$41.56 - $59.88 $26,058 - $37,544
627 Added 135.71%
1,089 $53,000
Q4 2020

Feb 02, 2021
SELL
$36.08 - $56.47 $1,804 - $2,823
-50 Reduced 9.77%
462 $25,000
Q3 2020

Nov 13, 2020
SELL
$33.26 - $40.48 $6,652 - $8,095
-200 Reduced 28.09%
512 $19,000
Q2 2020

Aug 13, 2020
BUY
$24.21 - $31.02 $581 - $744
24 Added 3.49%
712 $22,000
Q1 2020

May 13, 2020
BUY
$20.5 - $34.53 $14,104 - $23,756
688 New
688 $19,000
Q4 2019

Feb 14, 2020
BUY
$18.96 - $29.84 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$19.12 - $26.24 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$19.57 - $24.1 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
BUY
$12.14 - $20.46 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019
BUY
$11.24 - $18.5 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$12.5 - $15.38 $0 - $0
0 New
0 $0

Others Institutions Holding NEO

# of Institutions
276
Shares Held
127M
Call Options Held
581K
Put Options Held
115K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email